UBS Group
APMD

UBS Group’s Apnimed Inc APMD Stock Holding History

UBS Group’s Portfolio APMD Stock Details APMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.98M Buy
+181,847
New +$4.89M ﹤0.01% 4328

Other funds holding APMD

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Police & Firemen's Retirement System of New Jersey
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

UBS Group's APMD Position: Q3 2026 in Review

UBS Group opened a new position in Apnimed Inc (APMD) in Q3 2026: 181,847 shares worth $3.98M. The stake represents ﹤0.01% of the portfolio and ranks #4328 among its holdings.

20 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • UBS Group held 181,847 shares of Apnimed Inc worth $3.98M as of Q3 2026.
  • Apnimed Inc was a new UBS Group position in Q3 2026.
  • Apnimed Inc made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4328 holding.
  • 20 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.